Download PDF
Open Access
CC BY-NC-ND 4.0 · J Lab Physicians 2010; 2(01): 025-030
DOI: 10.4103/0974-2727.66709
Original Article

Lipid Profile of Type 2 Diabetic and Hypertensive Patients in the Jamaican Population

Authors

  • Lorenzo Gordon

    Department of Medicine, Basic Medical Sciences (Biochemistry Section), Jamaica

  • Dalip Ragoobirsingh

    Department of Basic Medical Sciences (Biochemistry Section), Jamaica

  • Errol Y St A Morrison

    Department of Basic Medical Sciences (Biochemistry Section), Jamaica

  • Eric Choo-Kang

    Department of Pathology, The University of the West Indies, Kingston 7, Jamaica

  • Donovan McGrowder

    Department of Pathology, The University of the West Indies, Kingston 7, Jamaica

  • E Martorell

    Department of Epidemiology, Provincial Centre of Hygiene and Epidemiology of Santiago de Cuba, Cuba

Source of Support: Nil
Further Information
Also available at
 PDF Download Permissions and Reprints

ABSTRACT

Aims: Previous studies have shown that diabetes mellitus (DM) increases the risk of cardiovascular diseases in females to a greater extent than in males. In this cross-sectional study, we evaluated the lipid profiles of type 2 diabetic males and females.

Materials and Methods: The study included 107 type 2 diabetic patients (41 males and 66 females), and 122 hypertensive type 2 diabetic patients (39 males and 83 females), aged 15 years and older. Total cholesterol (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-cholesterol (VLDL-C) and high density lipoprotein-cholesterol (HDL-C) concentrations were assayed for each group using standard biochemical methods.

Results: The mean TC, TG, VLDL-C, HDL-C and LDL-C concentrations, TG/HDL and LDL/HDL ratios were higher in type 2 diabetic and hypertensive type 2 diabetic patients compared with non-diabetic, and hypertensive non-diabetic control subjects, although these were not significant (P > 0.05). Hypertensive type 2 diabetic females had significantly higher serum TC (7.42 ± 1.63 mmol/L) than hypertensive non-diabetic males (5.76±1.57 mmol/L; P < 0.05). All the other lipid and lipoprotein parameters except HDL-C were non-significantly higher in females with type 2 DM and those with hypertension and type 2 DM, compared with type 2 diabetic and hypertensive type 2 diabetic males, respectively (P > 0.05).

Conclusion: This study demonstrated that dyslipidemia exists in our type 2 diabetic population with greater TC in hypertensive type 2 diabetic females compared with hypertensive type 2 diabetic males. This suggests that hypertensive type 2 diabetic females are exposed more profoundly to risk factors including atherogenic dyslipidemia compared with males.

Keywords

Females - hypertension - lipids - lipoprotein - males - type 2 diabetes mellitus


Publication History

Article published online:
29 January 2020

© 2010.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Fraser HS. The dilemma of diabetes: health care crisis in the Caribbean. Rev Panam Salud Publica 2001;9:61-4.
  • 2 Caribbean Health Research Council/PAHO. Managing diabetes in primary care in the Caribbean. St. Augustine, Trinidad and Tobago: CHRC; 2006. Available from: http://www.chrc-caribbean.org/files/Guidelines/DiabetesGuidelines.pdf [last cited on 2006].
  • 3 Wilks R, Rotimi C, Bennett F, McFarlane-Anderson N, Kaufman JS, Anderson SG, et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica. Diabet Med 1999;16:875-83.
  • 4 Ragoobirsingh D, Lewis-Fuller E, Morrison EY. The Jamaican diabetes survey: A protocol for the Caribbean. Diabetes Care 1995;18:1277-9.
  • 5 Gibbons GF. Hyperlipidaemia of diabetes. Clin Sci 1988;71:477-86.
  • 6 Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis, Epid, Pathophysiology, and management: Review article. JAMA 2002;287:19: 2570-81.
  • 7 Navab M, Berliner JA, Watson AD, Navab M, Berliner JA, Watson AD, et al. The yin and yang of oxidation in the development of the fatty streaks: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16:831-42.
  • 8 The Statistical Institute of Jamaica. Demographic statistics. Planning Institute of Jamaica, Kingston, Jamaica: 1993.
  • 9 Diabetes Mellitus: Report of a WHO Study Group (Review). World Health Organ Tech Rep Ser 1985;727:1-113.
  • 10 Kalk WJ, Constable J, Osler C, Rowe P. Evaluation of a new blood glucose meter and comparison with visually interpreted strips. S Afr Med J 1985;67:407-9.
  • 11 Huggett AS, Nixon DA. Use of glucose oxidase, peroxidase, and o-dianisidine in determination of blood and urinary glucose. Lancet 1957;273:368-70.
  • 12 Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
  • 13 Burstein M, Scholnick HR, Morfin R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
  • 14 Friedewald Wi′, Levy RI, Fredrickson DS. Estimation of the concentrationof lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  • 15 Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
  • 16 Feinstein A. Clinical epidemiology, the architecture of clinical research. 1st ed. WB Saunders Co; 1985.
  • 17 Idogun ES, Unuigbe EI, Ogunro PS, Akinola OT, Famodu AA. Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications. Pak J Med Sci (Part 1) 2007;23:708-12.
  • 18 Albrki, WM, Elzouki AN, El-Mansoury AM, Tashani OA. Lipid profiles in Libyan type II diabetics. J Sci Appls 2007;1:18-23.
  • 19 Khandekar S, Noeman SA, Muralidhar K, Gadallah M, Al-Sawaf KS. Central adiposity and atherogenic lipids in Saudi diabetics. Ann Saudi Med 1994;14:329-32.
  • 20 Onyemelukwe GC, Stafford WL. Serum lipids in Nigerians: the effect of diabetes mellitus. Trop Geogr Med 1981;33:323-8.
  • 21 Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983;118:489-96.
  • 22 Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Triglycerides and HDLcholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis 1996;119:235-45.
  • 23 Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992;70:733-7.
  • 24 Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-20.
  • 25 Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
  • 26 Goldberg IJ. Diabetic dyslipidaemia: causes and consequences. J Clin Endocrinol Metab 2001;8:965-71.
  • 27 Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest 1993;91:1743-52.
  • 28 Brunzell JD, Chait A. Diabetic dyslipidemia: pathology and treatment. In: Porte DJ, Sherwin RS, editors. Ellenberg and Rifkin′s Diabetes Mellitus. 5th ed. Stamford, Connecticut: Appleton and Lange; 1997. p. 1077.
  • 29 Vergès BL. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 1999;25:32-40.
  • 30 Akinkugbe OO. Noncommunicable diseases in Nigeria: the next epidemics Abayomi Memorial Lecture. Niger J Med Pract 2000;3:904-7.
  • 31 Ikem RT, Akinola NO, Balogun MO, Ohwovoriole AE, Akinsola A. What does the presence of hypertension portend in the Nigerian with noninsulin diabetes mellitus? West Afr J Med 2001;20:127-30.
  • 32 Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
  • 33 United Kingston Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997;20:1683-87.
  • 34 Cook CB, Erdman DM, Ryan GJ, Greenland KJ, Giles WH, Gallina DL, et al. The pattern of dyslipidaemia among African-Americans with type 2 diabetes. Diabetes Care 2000;3:319-24.
  • 35 Genest J, Frohlich J, Fodor G, McPherson R; Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: Summary of the 2003 update. CMAJ 2003;169:921-4.
  • 36 Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1997;11:137-41.
  • 37 Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis 1998;136:25-31.
  • 38 Sniderman AD, Scantlebury T, Cianfione K. Hypertriglyceridaemic hyperpob: the unappreciated atherogenic dyslipidaemia in type 2 diabetes mellitus. Ann Intern Med 2001;135:447-59.
  • 39 Gowri MS, Vander Westhuyzen DR, Bridges SR, Anderson JW. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol 1999;19:2226-33.